Information Provided By:
Fly News Breaks for January 21, 2020
TDOC
Jan 21, 2020 | 08:38 EDT
JPMorgan analyst Lisa Gill raised her price target for Teladoc Health to $112 from $94 and keeps an Overweight rating on the shares. Around the JPMorgan Healthcare conference, Teladoc announced several positive developments, including the acquisition of InTouch Health, Q4 revenue and visit guidance increases, and the company's commentary around robust selling momentum heading into 2020, Gill tells investors in a research note. The analyst increased her estimates to reflect these developments.
News For TDOC From the Last 2 Days
There are no results for your query TDOC
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.